| Chaitanya Nagulapalli, MD | |
|
2 Millstone Ct, Cranbury, NJ 08512-2006 | |
| (973) 997-1472 | |
| Not Available |
| Full Name | Chaitanya Nagulapalli |
|---|---|
| Gender | Female |
| Speciality | Hospitalist |
| Experience | 27 Years |
| Location | 2 Millstone Ct, Cranbury, New Jersey |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1093731648 | NPI | - | NPPES |
| 47915-NON PAR# | Other | NJ | UHP |
| 0102431 | Medicaid | NJ | |
| P00689256-MERCER | Other | NJ | RAILROAD MEDICARE |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207R00000X | Internal Medicine | 25MA07992100 (New Jersey) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Princeton Homecare Services Hospice Program | West windsor, NJ | Hospice |
| University Medical Center Of Princeton At Plainsboro | Plainsboro, NJ | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Clinical Health Care Associates Of New Jersey Pc | 0749180198 | 664 |
News Archive
A new form of congenital muscular dystrophy has been discovered which is caused by mutations in a previously un-linked gene.
Steps for reducing the risk of stroke in patients undergoing heart surgery are detailed in a new American Heart Association Scientific Statement, "Considerations for Reduction of Risk of Perioperative Stroke for Adult Patients Undergoing Cardiac and Thoracic Aortic Operations," published today in the American Heart Association's flagship journal Circulation.
Tokyo Medical and Dental University research team demonstrated that osteocytes have a crucial role in orthodontic tooth movement as the major source of receptor activator of nuclear factor-κB ligand (RANKL), a protein crucial to bone remodeling.
The skin is constantly challenged, and very often harmed, by environmental stressors such as UV radiation and chemicals. To cope with UV radiation, various skin cells have evolved a complex protective antioxidant defense system.
Eisai Co., Ltd. has announced that its U.S. subsidiary Eisai Inc. has received approval from the U.S. Food and Drug Administration (FDA) for an additional indication for Eisai's in-house developed novel anticancer agent Lenvima (lenvatinib mesylate) in combination with everolimus for the treatment of patients with advanced renal cell carcinoma following one prior anti-angiogenic therapy.
› Verified 2 days ago
| Entity Name | Clinical Health Care Associates Of New Jersey Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1447260435 PECOS PAC ID: 0749180198 Enrollment ID: O20040421001473 |
News Archive
A new form of congenital muscular dystrophy has been discovered which is caused by mutations in a previously un-linked gene.
Steps for reducing the risk of stroke in patients undergoing heart surgery are detailed in a new American Heart Association Scientific Statement, "Considerations for Reduction of Risk of Perioperative Stroke for Adult Patients Undergoing Cardiac and Thoracic Aortic Operations," published today in the American Heart Association's flagship journal Circulation.
Tokyo Medical and Dental University research team demonstrated that osteocytes have a crucial role in orthodontic tooth movement as the major source of receptor activator of nuclear factor-κB ligand (RANKL), a protein crucial to bone remodeling.
The skin is constantly challenged, and very often harmed, by environmental stressors such as UV radiation and chemicals. To cope with UV radiation, various skin cells have evolved a complex protective antioxidant defense system.
Eisai Co., Ltd. has announced that its U.S. subsidiary Eisai Inc. has received approval from the U.S. Food and Drug Administration (FDA) for an additional indication for Eisai's in-house developed novel anticancer agent Lenvima (lenvatinib mesylate) in combination with everolimus for the treatment of patients with advanced renal cell carcinoma following one prior anti-angiogenic therapy.
› Verified 2 days ago
| Entity Name | Princeton Healthcare Affiliated Physicians Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1518194323 PECOS PAC ID: 2567598022 Enrollment ID: O20100413000141 |
News Archive
A new form of congenital muscular dystrophy has been discovered which is caused by mutations in a previously un-linked gene.
Steps for reducing the risk of stroke in patients undergoing heart surgery are detailed in a new American Heart Association Scientific Statement, "Considerations for Reduction of Risk of Perioperative Stroke for Adult Patients Undergoing Cardiac and Thoracic Aortic Operations," published today in the American Heart Association's flagship journal Circulation.
Tokyo Medical and Dental University research team demonstrated that osteocytes have a crucial role in orthodontic tooth movement as the major source of receptor activator of nuclear factor-κB ligand (RANKL), a protein crucial to bone remodeling.
The skin is constantly challenged, and very often harmed, by environmental stressors such as UV radiation and chemicals. To cope with UV radiation, various skin cells have evolved a complex protective antioxidant defense system.
Eisai Co., Ltd. has announced that its U.S. subsidiary Eisai Inc. has received approval from the U.S. Food and Drug Administration (FDA) for an additional indication for Eisai's in-house developed novel anticancer agent Lenvima (lenvatinib mesylate) in combination with everolimus for the treatment of patients with advanced renal cell carcinoma following one prior anti-angiogenic therapy.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Chaitanya Nagulapalli, MD 2 Millstone Ct, Cranbury, NJ 08512-2006 Ph: (609) 613-5132 | Chaitanya Nagulapalli, MD 2 Millstone Ct, Cranbury, NJ 08512-2006 Ph: (973) 997-1472 |
News Archive
A new form of congenital muscular dystrophy has been discovered which is caused by mutations in a previously un-linked gene.
Steps for reducing the risk of stroke in patients undergoing heart surgery are detailed in a new American Heart Association Scientific Statement, "Considerations for Reduction of Risk of Perioperative Stroke for Adult Patients Undergoing Cardiac and Thoracic Aortic Operations," published today in the American Heart Association's flagship journal Circulation.
Tokyo Medical and Dental University research team demonstrated that osteocytes have a crucial role in orthodontic tooth movement as the major source of receptor activator of nuclear factor-κB ligand (RANKL), a protein crucial to bone remodeling.
The skin is constantly challenged, and very often harmed, by environmental stressors such as UV radiation and chemicals. To cope with UV radiation, various skin cells have evolved a complex protective antioxidant defense system.
Eisai Co., Ltd. has announced that its U.S. subsidiary Eisai Inc. has received approval from the U.S. Food and Drug Administration (FDA) for an additional indication for Eisai's in-house developed novel anticancer agent Lenvima (lenvatinib mesylate) in combination with everolimus for the treatment of patients with advanced renal cell carcinoma following one prior anti-angiogenic therapy.
› Verified 2 days ago
Ann Elaine Smelkinson, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 2650 Us Highway 130, Suite F, Cranbury, NJ 08512 Phone: 609-860-8000 Fax: 609-860-8004 | |
Dr. Eric S. Cantor, MD Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 1 Cedar Brook Drive, Cranbury, NJ 08512 Phone: 609-662-2770 |